SCHEMBL6000360

SCHEMBL6000360

CNC(C(=O)O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3711245 0.84
Hydrochloric Acid SCHEMBL8090554 0.82 TP53 (0.32)
SCHEMBL8986552 0.80
SCHEMBL8986556 0.80
SCHEMBL12622537 0.80 FNTA (0.32)
SCHEMBL8986561 0.80
SCHEMBL1065904 0.78 FFAR3 (0.36)
SCHEMBL27839519 0.78
SCHEMBL11741876 0.76 TSHR (0.35)
SCHEMBL11739939 0.76 TSHR (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0348509-B1 ANTI-RETROVIRAL DRUG TSUMURA &amp; CO. (JP) 1993-03-24 EP claimed
EP-0348509-A1 ANTI-RETROVIRAL DRUG TSUMURA &amp; CO. (JP) 1990-01-03 EP claimed
JP-2069415-A None JP disclosed
EP-3831824-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) 2021-06-09 EP disclosed
WO-2020025030-A1 PREPARATION AND APPLICATION OF AROMATIC COMPOUND HAVING IMMUNOREGULATORY FUNCTION 上海轶诺药业有限公司 2020-02-06 WO disclosed
WO-2020024997-A1 PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION 上海轶诺药业有限公司 2020-02-06 WO disclosed
EP-2562155-B1 HYDROXAMIC ACID DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 2019-06-05 EP disclosed
US-20170097567-A1 METHOD FOR PRODUCING POLYMER SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-06 US disclosed
US-20160229940-A1 POLYMER, RESIST COMPOSITION, AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-08-11 US disclosed
US-20160220689-A1 MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES STARPHARMA PTY LTD. (AU) 2016-08-04 US disclosed
US-9073821-B2 Hydroxamic acid derivative TAISHO PHARMACEUTICAL CO., LTD (JP) 2015-07-07 US disclosed
WO-2001014335-A1 PROCESS FOR PREPARATION OF PAROXETIN INTERMEDIATE SMITHKLINE BEECHAM P.L.C. (GB) 2001-03-01 WO disclosed
EP-0348509-B1 ANTI-RETROVIRAL DRUG TSUMURA &amp; CO. (JP) 1993-03-24 EP disclosed
EP-0348509-B1 ANTI-RETROVIRAL DRUG TSUMURA &amp; CO. (JP) 1993-03-24 EP disclosed
EP-0348509-A4 ANTI-RETROVIRAL DRUG 1990-09-05 EP disclosed
EP-0367974-A1 Cis-complexes with a 1,3-diaminopropane derivative as a ligand, methods for their preparation and pharmaceutical agents containing such complexes BEHRINGWERKE Aktiengesellschaft (DE) 1990-05-16 EP disclosed
JP-H0269415-A ANTI-RETROVIRUS AGENT TSUMURA & CO 1990-03-08 JP disclosed
EP-0348509-A1 ANTI-RETROVIRAL DRUG TSUMURA &amp; CO. (JP) 1990-01-03 EP disclosed
EP-0348509-A1 ANTI-RETROVIRAL DRUG TSUMURA &amp; CO. (JP) 1990-01-03 EP disclosed
WO-1989005141-A1 ANTI-RETROVIRAL DRUG TSUMURA JUNTENDO, INC. (JP) 1989-06-15 WO disclosed